| Literature DB >> 17684748 |
L Bazzichi1, T Giuliano, A Rossi, A Mazzoni, T Grazzini, F De Feo, C Giacomelli, F Scatena, S Bombardieri.
Abstract
We report on a female case of rheumatoid arthritis (RA) with hepatitis C virus comorbidity. The patient was treated once weekly over ten consecutive weeks with Adacolumn device. Clinical assessment and HCV-RNA concentration were monitored at weeks-1, 4, 9, 14 and during follow-up over 6 months. At the end of the treatment: the number of tender and swollen joints, patient's global assessment of disease activity (VAS), physician's VAS, C-reactive protein (CRP) decreased, respectively; ACR response was >20. This improvement was maintained for over 2 months. At week 38, the patient was re-treated achieving again an ACR response >20.Entities:
Mesh:
Substances:
Year: 2007 PMID: 17684748 DOI: 10.1007/s00296-007-0427-1
Source DB: PubMed Journal: Rheumatol Int ISSN: 0172-8172 Impact factor: 2.631